Chronic renal disease progression: treatment strategies and potassium intake.
暂无分享,去创建一个
[1] H. Chen,et al. Hypokalemia Is Associated with Increased Mortality Rate in Chronic Hemodialysis Patients , 2011, Blood Purification.
[2] R. Mactier,et al. Renal Association Clinical Practice Guideline on Haemodialysis , 2011, Nephron Clinical Practice.
[3] M. Tonelli,et al. The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[4] M. Burnier,et al. Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids , 2011, BMC nephrology.
[5] C. Herzog,et al. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. , 2011, Kidney international.
[6] R. Agarwal,et al. Should All Hypertensive Dialysis Patients Receive a Blocker of the Renin-Angiotensin System? , 2010, Current hypertension reports.
[7] Allen R Nissenson,et al. Dietary potassium intake and mortality in long-term hemodialysis patients. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] G. Cavada,et al. A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[9] B. Pitt,et al. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[10] M. Tonelli,et al. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[11] K. Kalantar-Zadeh,et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[12] K. Kalantar-Zadeh,et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[13] G. Bakris,et al. Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease: Findings From Propensity-Matched Studies , 2010, Circulation. Heart failure.
[14] M. Tonelli,et al. Dialysate potassium and risk of death in chronic hemodialysis patients. , 2010, Journal of nephrology.
[15] Y. Toya,et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. , 2009, Atherosclerosis.
[16] L. Appel,et al. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. , 2009, Archives of internal medicine.
[17] G. Knoll,et al. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Peritoneal Dialysis: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[18] J. Townend,et al. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. , 2009, Journal of the American College of Cardiology.
[19] R. Sherman,et al. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[20] M. Valsecchi,et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] M. Zhan,et al. The frequency of hyperkalemia and its significance in chronic kidney disease. , 2009, Archives of internal medicine.
[22] S. Kageyama,et al. Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients , 2009, Cardiology.
[23] S. Navaneethan,et al. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[24] Olivier Moranne,et al. Timing of onset of CKD-related metabolic complications. , 2009, Journal of the American Society of Nephrology : JASN.
[25] Tsutomu Inoue,et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] J. Ingelfinger. Aliskiren and dual therapy in type 2 diabetes mellitus. , 2008, The New England journal of medicine.
[27] Takahiko Nakagawa,et al. Hypokalemic nephropathy is associated with impaired angiogenesis. , 2008, Journal of the American Society of Nephrology : JASN.
[28] Ping Zhang,et al. Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. , 2007, American journal of physiology. Renal physiology.
[29] S. Greenland,et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[30] Raymond Vanholder,et al. EBPG guideline on nutrition. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] E. Hodson,et al. Nutrition and growth in kidney disease: CARI guidelines. , 2007, Australian family physician.
[32] Y. Won,et al. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] M. Kiernan,et al. Uremic neuropathy: Clinical features and new pathophysiological insights , 2007, Muscle & nerve.
[34] J. Craig,et al. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. , 2006, The Cochrane database of systematic reviews.
[35] F. Zannad,et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. , 2006, Kidney international.
[36] Y. Dohi,et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] A. Zanchetti,et al. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. , 2006, Kidney international.
[38] K. Kalantar-Zadeh,et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[39] N. Powe,et al. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] M. Kiernan,et al. Altered motor nerve excitability in end-stage kidney disease. , 2005, Brain : a journal of neurology.
[41] B. C. Kwan,et al. Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[42] G. Coppolino,et al. The effect of two different protocols of potassium haemodiafiltration on QT dispersion. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] R Gaggi,et al. Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. , 2005, Contributions to nephrology.
[44] B. Kestenbaum,et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[45] J. Fink,et al. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] G. Braunstein,et al. Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction , 2004, Annals of Internal Medicine.
[47] G. Chertow,et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.
[48] C. Specchia,et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[49] M. Ashton,et al. Safety and Tolerability of High-Dose Angiotensin Receptor Blocker Therapy in Patients with Chronic Kidney Disease: A Pilot Study , 2004, American Journal of Nephrology.
[50] Bruce Kupelnick,et al. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .
[51] J. Beto,et al. Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. , 2004, Journal of the American Dietetic Association.
[52] Christopher H Schmid,et al. Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.
[53] S. Fukuhara,et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. , 2003, Kidney international.
[54] W. Owen,et al. Toward a Continuous Quality Improvement Paradigm for Hemodialysis Providers with Preliminary Suggestions for Clinical Practice Monitoring and Measurement , 2003, Hemodialysis international. International Symposium on Home Hemodialysis.
[55] A. S. Segal,et al. Hyperkalemia: An adaptive response in chronic renal insufficiency. , 2002, Kidney international.
[56] N. Murray,et al. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. , 2002, Brain : a journal of neurology.
[57] C. van Walraven,et al. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. , 2002, The American journal of medicine.
[58] Y. G. Kim,et al. Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. , 2001, American journal of physiology. Renal physiology.
[59] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[60] G. Chertow,et al. Cardiac arrest and sudden death in dialysis units. , 2001, Kidney international.
[61] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .
[62] J. Kopple,et al. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[63] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[64] A. Cupisti,et al. Potassium Removal Increases the QTc Interval Dispersion during Hemodialysis , 1999, Nephron.
[65] R. Toto,et al. Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment , 1998 .
[66] D. Macpherson,et al. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? , 1998, Archives of internal medicine.
[67] F. Epstein,et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[68] C. Wingo,et al. The effects of potassium depletion and supplementation on blood pressure: a clinical review. , 1997, The American journal of the medical sciences.
[69] P. Whelton,et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.
[70] K. Iseki,et al. Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[71] B. Redaelli. Electrolyte modelling in haemodialysis--potassium. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[72] R. Agarwal,et al. Pathophysiology of potassium absorption and secretion by the human intestine , 1994 .
[73] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[74] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[75] D. Van Dyk,et al. Causes of death in patients with end-stage renal disease treated by dialysis in a center in Israel. , 1992, Israel journal of medical sciences.
[76] R. Latini,et al. Ventricular arrhythmias and four-year mortality in haemodialysis patients , 1992, The Lancet.
[77] F P Cappuccio,et al. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. , 1991, Journal of hypertension.
[78] A. Dyer,et al. Findings of the International Cooperative INTERSALT Study , 1991, Hypertension.
[79] Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. , 1991, Journal of cardiovascular pharmacology.
[80] E G Lowrie,et al. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[81] K P Offord,et al. Association of hypokalemia, aldosteronism, and renal cysts. , 1990, The New England journal of medicine.
[82] G Block,et al. Validation of a self-administered diet history questionnaire using multiple diet records. , 1990, Journal of clinical epidemiology.
[83] R. Prineas,et al. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. , 1987, The American journal of cardiology.
[84] A. Tzamaloukas,et al. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. , 1987, American journal of nephrology.
[85] J. Stanton,et al. Blood pressure and nutrient intake in the United States , 1984 .
[86] M. Shibata,et al. Clinical study of complications in dialyzed diabetics. , 1983, The Tohoku journal of experimental medicine.
[87] D. Kem,et al. Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. , 1983, Kidney international.
[88] P. Degoulet,et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. , 1982, Nephron.
[89] E. Michelson,et al. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. , 1980, Kidney international.
[90] K. Bock,et al. Symptoms and course of chronic hypokalemic nephropathy in man. , 1977, Clinical nephrology.
[91] B. B. Johnson,et al. Aldosterone excretion in normal subjects depleted of sodium and potassium. , 1957, The Journal of clinical investigation.
[92] W. Schwartz,et al. The nephropathy of potassium depletion; a clinical and pathological entity. , 1956, The New England journal of medicine.
[93] J. Darragh,et al. Potassium and sodium restriction in the normal human. , 1955, The Journal of clinical investigation.